Candidates for intrathecal treatment are typically those with cancers that have metastasized to the CNS or those at high risk for such metastases. This includes patients with certain types of leukemia and lymphoma, as well as those with solid tumors that frequently spread to the brain or spinal cord. The decision to use intrathecal treatment is made based on a thorough evaluation of the patient's overall health, cancer type, and specific clinical circumstances.
